Discovering the relationships at the heart of biology to cure disease
Joined August 2020
- Tweets 202
- Following 538
- Followers 1,434
- Likes 491
28 Photos and videos
Pinned Tweet
22 Feb 2023
We were deeply honoured to have Sir Paul Nurse @TheCrick join us to officially open our flagship integrated dry-wet lab in London's @KQ_London . Thank you Sir Paul Nurse for your inspirational speech and joining our CEO @welshmanofkent inaugurating our magnificent new home!
2
26
7,089
Relation retweeted
23 Dec 2025
Wow! This is so cool and way more fun than boring BioRender! Plus, developing fine motor skills through hand drawing and creativity without limitations in shapes or form! Try it out yourself here chat.figurelabs.ai/invitatio…
7
120
842
61,836
Relation retweeted
10 Dec 2025
‘Lab-in-the-loop’ approach seeks to ensure targets are causally linked in bone health, immunology and metabolic disease.
longevity.technology/news/re…
#longevity #biotech #investment #osteoporosis #bonedisease #aging
1
2
5
626
9 Dec 2025
Today we’re announcing a new collaboration between @RelationRx and @Novartis to accelerate the discovery of drug targets for atopic diseases. These conditions affect hundreds of millions of people globally, and better understanding their underlying biology is essential to delivering more effective medicines.
As our CEO David Roblin shared today in Bloomberg, too many programmes fail because we don’t yet understand the biology well enough at the start. This partnership brings together Novartis’ strength in immunology with Relation’s patient-derived data and AI platform to help change that.
The patient is waiting.
bloomberg.com/news/articles/…
globenewswire.com/news-relea…
5
12
3,079
1 Dec 2025
Huge achievement by the Rosalind team at @RelationRx showing our now award-winning SOTA approach to DNA transformer models 🔥
Join us at @NeurIPSConf #NeurIPS and meet us in person: @wildtypehuman, @cristianregep, Lindsay Edwards, Rosie Rodriguez, Sara-Jane Dunn, and Alice Del Vecchio!
30 Nov 2025
In the last few years I’ve built a DNA modelling team in industry @RelationRx. Our recent work just won 🏆 Best Paper at the @AI4D3 workshop at #NeurIPS, and we’ll be giving a talk. A few co-authors and I will be in San Diego this week and would love to connect with others passionate about DNA modelling.
🎤 Dec 6th, — San Diego Convention Center, Upper Level, Room 28A–E
🔗 Read the paper:
biorxiv.org/content/10.1101/…
1
4
7
877
Relation retweeted
30 Nov 2025
In the last few years I’ve built a DNA modelling team in industry @RelationRx. Our recent work just won 🏆 Best Paper at the @AI4D3 workshop at #NeurIPS, and we’ll be giving a talk. A few co-authors and I will be in San Diego this week and would love to connect with others passionate about DNA modelling.
🎤 Dec 6th, — San Diego Convention Center, Upper Level, Room 28A–E
🔗 Read the paper:
biorxiv.org/content/10.1101/…
2
3
8
1,182
Relation retweeted
29 Nov 2025
Heading to San Diego for #NeurIPS2025 , ping me if you want to chat on active learning, reinforcement learning, and applications of deep learning in genomics (single cell, spatial, etc).
1
3
30
4,065
Relation retweeted
24 Nov 2025
Hiring someone for a very exciting project at the intersection of wet-lab and dry-lab. Generating spatial transcriptomics data and then analysing it. You need to be happy to get your hands dirty...!
5
20
73
12,277
21 Nov 2025
Relation co-founder Jake Taylor-King (@wildtypehuman) speaking at @SlushHQ on how AI will transform drug discovery!
1
1
2
229
At @raais 2025, Benjamin Swerner Co-Founder and COO of @RelationRx reflected on why this century will be defined by two breakthroughs: building intelligence independent of humans and reducing the world’s disease burden.
Be part of the community at raais(dot)co, rsvps open!
2
4
290
Relation retweeted
23 Sep 2025
This is an amazing line up! Come one and all :D
19 Sep 2025
High-Content CRISPR Screening Conference
March 18-19, 2026 | Vienna, Austria
Abstract submission is now open! Don’t miss the chance to hear from an outstanding line-up of speakers and connect with leading researchers in the field.
Register now: perturb2026.bio/
ALT We invite researchers from across the globe to share their latest work and join the discussion shaping the future of CRISPR screening and genome editing. Scientific themes include * CRISPR-based screening strategies * Perturb-seq and CROP-seq methods * Computational analysis and data interpretation * AI models of human cells * Imaging-based CRISPR screens Date: March 18 & 19, 2026 Location: Vienna, Austria
1
4
516
Relation retweeted
23 Sep 2025
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18–19, 2026, in Vienna, Austria.
The registration is now open via the website:
perturb2026.bio/
Meet the Speaker: Jake P. Taylor-King
@wildtypehuman
@RelationRx
ALT Prior to co-founding Relation Therapeutics, Dr. Jake Taylor-King was an academic and industry researcher interested in company formation at the intersection of technology, computation, and the clinic. Previously an award-winning mathematician (G-Research prize, Lee Segel Prize), he has degrees from Bristol, Oxford, Cambridge, before later transitioning to biomedicine and genomics at ETH Zürich. Jake’s role as Chief Innovation Officer at Relation cuts across many functions, including leading an experimental technology development group, engaging in ML research, and designing clinical studies for patient tissue access.
1
2
7
392
Relation retweeted
19 Sep 2025
AI is accelerating the future of medicine.
NVIDIA is collaborating with healthcare and life sciences leaders across the UK to unlock faster, more precise drug discovery.
From Hologen’s complex human biology models and @RelationRx lab-in-the-loop experimentation, to @InSilicoUK’s digital twins and @Basecamp_Res’s expansive datasets—AI is powering breakthroughs that bring new therapies closer to patients.
The next era of healthcare starts here.
2
5
14
1,451
Relation retweeted
6 Sep 2025
Making AI useful in the lab: the missing math of active learning
A call for greater first-principles theory to power lab-in-the-loop science
with @BlackHC and @paulmorio
3
25
153
16,111
Relation retweeted
5 Sep 2025
With Paul Scherer of @RelationRx and Andreas Kirsch (@BlackHC) we give our take on how to exploit a very simple relationship (the bias-variance tradeoff) to build a class of general AL strategies.
arxiv.org/abs/2509.04363
1
4
24
1,225
Relation retweeted
5 Sep 2025
Much of the active learning literature avoids modelling the bias and noise of the underlying experimental system...
4
21
175
13,119
Relation retweeted
2 Apr 2025
Relationships That Make TechBio Go 'Round. Listen to David Roblin, CEO of @RelationRx on The Long Run. timmermanreport.com/2025/03/…
2
4
1,590
Relation retweeted
26 Feb 2025
I love seeing @RelationRx's term "lab-in-the-loop" making it into the modern parlance!
25 Feb 2025
Lab-in-the-loop therapeutic antibody design
At @PrescientDesign @genentech we have spent 3 years reimagining drug discovery. We built a machine learning system to design and execute experiments. Here's how it works and what we can do 🧵
1/
2
7
919
Relation retweeted
17 Feb 2025
Read the @scTrends_update take on the AI arms race to generate single-cell data
sctrends.org/p/the-single-ce…
Thanks @AdamCribbs !
6
10
920
Relation retweeted
15 Feb 2025
How big a market do early stage VCs think there actually is for protein foundation models? Remember, the key cost and hurdle is clinical trails, not a lack of molecules to try drugging people with.
(Side note: we need new targets and that's what @RelationRx is about)
13 Feb 2025
i wonder if, after every new protein foundation company starts up, the vc's that invested in the last one longingly look at the new one and then back to the one they invested in. "did i make the right choice?" they think. "that new one has deepmind people...", they muse, "...but mine has a cooler name". the grass is always greener
1
3
19
2,923
Relation retweeted
4 Feb 2025
🚀 Have You Read the UK biotech financing report yet? ➡️ biotechfinance.org/
Our latest #UKbiotech financing report is packed with inspiring case studies of groundbreaking companies securing funding to drive 🚀 innovation, fuel R&D, and strengthen the UK’s position as a #GlobalBiotech leader 👏
A great example is @RelationRx, which closed an impressive $60 million seed round last year—a testament to the sector’s resilience and growth
📖 Dive into the report to discover more success stories and see how the UK is maintaining its competitive edge in #biotech ➡️ biotechfinance.org/
Special thanks to David Roblin, CEO of @RelationRx for his thoughts 🧠
#InvestinBiotech
1
1
326